However, AKT overexpression partly reduced the inhibitory effects of lomerizine 2HCl on the AKT/mTOR signaling pathway and weakened the inhibitory actions of lomerizine 2HCl on CRC cell growth. This evidence concerns the gene MTOR and colorectal carcinoma.